Calendario de vacunaciones sistemáticas del adolescente y adulto recomendado por la Sociedad Española de Medicina Preventiva, Salud Pública e Higiene (actualización del año 2014)

Salleras, L.; Bayas, JM; Campins, Miguel Angel Solana; Castrodeza, Javier; Domínguez, Ana; Domínguez, Viviana; Arrazola, P. J; Fernández‐Crehuet, J.; Fernández, S.; Forcada, José; Juanes, J.R. de; López-Gigosos, Rosa; Pastor, Vicente; Sáenz, Melio

doi:10.1016/s1576-9887(14)70089-5

Cited by 10 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Assessing vaccination needs for any patient suffering from chronic disease requires a through vaccine history including systematic immunization. Patients with IBD, as is also the case with the general population, should receive Table II shows the adult vaccination schedule used in Spain (27).…”

Section: Adult Systematic Immunization Schedulementioning

confidence: 99%

“…Conjugate vaccines against Haemophilus influenzae type b (Hib) and Meningococcus C (MCC) are included in the systematic immunization schedule for children in Spain, and are also recommended for adults at risk and immunodepressed individuals (27). In our country, patients with IBD who did not receive these vaccines during childhood and who are treated or apt to be treated with immunosuppressants, should be immunized with one dose of MCC vaccine and one dose of Hib vaccine (1,17,84).…”

Section: Meningococcus and Haemophilus Influenzae Type B (Hib) Conjugmentioning

confidence: 99%

See 1 more Smart Citation

Vaccination of patients with inflammatory bowel disease: Practical recommendations

Campins

Cossio

Martínez

et al. 2013

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

Patients with inflammatory bowel disease (IBD) have a greater risk of infection associated with the endogenous immunosuppression brought about by their underlying disease as well as the exogenous immunosuppression resulting from their therapies. In the last few years guidelines and consensus papers have been issued on the indication of vaccines for these patients as primary prevention of infection. However, vaccine coverage is low, likely because the risk for infection and both safety and efficacy concerns regarding vaccines are scarcely perceived in such cases. The available scientific evidence shows that immunization is safe for most preparations, and bears no association with an increased risk for disease activity. This paper reviews the available scientific literature, and provides recommendations on the vaccination of adults with IBD.

show abstract

Section: Adult Systematic Immunization Schedulementioning

confidence: 99%

Section: Meningococcus and Haemophilus Influenzae Type B (Hib) Conjugmentioning

confidence: 99%

Vaccination of patients with inflammatory bowel disease: Practical recommendations

Campins

Cossio

Martínez

et al. 2013

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

show abstract

Conceptos generales. Calendarios de vacunación sistemática del niño y del adulto en España. Impacto de los programas de vacunación

Martínez

Pardo

Ilario

2015

Enfermedades Infecciosas y Microbiología Clínica

View full text Add to dashboard Cite

Vaccines that should be administered to patients receiving treatment with immunosuppressive, immunomodulatory and/or biological drugs

Peremiquel-Trillas

Leguízamo

Ostos

et al. 2018

Medicina Clínica (English Edition)

View full text Add to dashboard Cite

Calendario de vacunaciones sistemáticas del adolescente y adulto recomendado por la Sociedad Española de Medicina Preventiva, Salud Pública e Higiene (actualización del año 2014)

Cited by 10 publications

References 0 publications

Vaccination of patients with inflammatory bowel disease: Practical recommendations

Vaccination of patients with inflammatory bowel disease: Practical recommendations

Conceptos generales. Calendarios de vacunación sistemática del niño y del adulto en España. Impacto de los programas de vacunación

Vaccines that should be administered to patients receiving treatment with immunosuppressive, immunomodulatory and/or biological drugs

Contact Info

Product

Resources

About